Abstract
Introduction and objectives
The development of HTLV-1-associated myelopathy (HAM/TSP) in HTLV-1-infected individuals is probably a multi-factor event, in which the immune system plays a crucial role. The efficiency of the host immunity seems to be one of the in vivo determining factors of the proviral load levels and is regulated by genes associated with MHC class I alleles (HLA). Protection or predisposition to HTLV-1-associated diseases according to individual HLA profile was shown in Japanese studies. The present work tested for HLA alleles previously related to protection or susceptibility to HTLV-1-associated myelopathy in a cohort study (GIPH) from Brazil.
Methods
A total of 93 HTLV-1-infected individuals participated in the study, as follows: 84 (90.3%) asymptomatic and 9 (9.7%) with HAM/TSP. Alleles related to protection (A*02, Cw*08) and susceptibility (B*07, Cw*08 and B*5401) were tested by the PCR-SSP method.
Results
Allele A*02 was more frequent in the asymptomatic group and in its absence, Cw*07 was correlated with HAM/TSP (P = 0.002). Allele B*5401 was not present in the Brazilian population. Alleles B*07 and Cw*08 were not different between the groups
Discussion
The presence of HLA-A2 elicits a stronger cytotoxic response, which is involved in the HTLV-1 proviral load reduction. This study confirmed a tendency of this allele to protect against HAM-TSP. Therefore, A*02 might be of interest for researches involved with HTLV-1 vacine.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Osame M, Janssen R, Kubota H et al (1990) Nationwide survey on Human T-cell leukemia/lymphoma virus type I associated myelopathy in Japan. Association with blood transfusion. Ann Neurol 28:50–56
Gessain A, Gout O (1992) Chronic myelopathy associated with human T-lymphotropic virus type I (HTLV-I). Ann Int Med 117:933–946
Jeffery KJM, Usuku K, Matsumoto W et al (1999) HLA alleles determine human T-lymphotropic virus-I (HTLV-I) proviral load and the risk of HTLV-I associated myelopathy. Proc Natl Acad Sci USA 96:3848–3853
Jeffery KJM, Siddiqui AA, Bunce M et al (2000) The influence of HLA class I alleles and heterozygosity on the outcome of human T cell lymphotropic virus type I infection. J. Immunol 165:7278–7284
Rafatpanah H, Pravica V, Faridhosseini R et al (2007) Association between HLA-DRB1*01 and HLA-Cw*08 and outcome following HTLV-I infection. Iran J Immunol 4(2):94–100
Proietti FA, Carneiro-Proietti AB, Catalan-Soares BC et al (2005) Global epidemiology of HTLV-I infections and associated diseases. Oncogene 24:6058–6068
Imanishi T, Akaza T, Kimura A, Tokunaga K, Gojobori T (1992) Allele and haplotype frequencies for HLA and complement loci in various ethnic groups. In: Tsuji K, Aizawa M, Sasazuki T (eds) HLA 1991. Oxford University Press, New York, p 1065
Borducchi DM, Gerbase DeLima M, Morgum A et al (2003) Human leucocyte antigen and human T-cell lymphotropic virus type 1 associated diseases in Brazil. Br J Haematol 123:954–955
Acknowledgments
Minas Gerais State Centre of Hematology and Blood Transfusion (Fundação Hemominas), Fundação de Amparo à Pesquisa de Minas Gerais (Fapemig) and Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq) supported this work. This work was performed by researchers participating in the HTLV Interdisciplinary Research Group (GIPH), Brazil.
Author information
Authors and Affiliations
Consortia
Corresponding author
Rights and permissions
About this article
Cite this article
Catalan-Soares, B.C., Carneiro-Proietti, A.B.F., Da Fonseca, F.G. et al. HLA class I alleles in HTLV-1-associated myelopathy and asymptomatic carriers from the Brazilian cohort GIPH. Med Microbiol Immunol 198, 1–3 (2009). https://doi.org/10.1007/s00430-008-0096-z
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00430-008-0096-z